成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart 0 Sign in  

[ CAS No. 147804-30-6 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 147804-30-6
Chemical Structure| 147804-30-6
Structure of 147804-30-6 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 147804-30-6 ]

Related Doc. of [ 147804-30-6 ]

Alternatived Products of [ 147804-30-6 ]
Product Citations

Product Details of [ 147804-30-6 ]

CAS No. :147804-30-6 MDL No. :MFCD07779385
Formula : C11H19NO3 Boiling Point : No data available
Linear Structure Formula :- InChI Key :ULSBMKGFFFMGOI-UHFFFAOYSA-N
M.W : 213.27 Pubchem ID :22135564
Synonyms :

Calculated chemistry of [ 147804-30-6 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.91
Num. rotatable bonds : 3
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 60.41
TPSA : 42.07 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.81 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.85
Log Po/w (XLOGP3) : 1.11
Log Po/w (WLOGP) : 1.41
Log Po/w (MLOGP) : 1.15
Log Po/w (SILICOS-IT) : 1.62
Consensus Log Po/w : 1.63

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.66
Solubility : 4.63 mg/ml ; 0.0217 mol/l
Class : Very soluble
Log S (Ali) : -1.59
Solubility : 5.53 mg/ml ; 0.0259 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.51
Solubility : 6.56 mg/ml ; 0.0308 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.62

Safety of [ 147804-30-6 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 147804-30-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 147804-30-6 ]

[ 147804-30-6 ] Synthesis Path-Downstream   1~5

  • 1
  • [ 147804-30-6 ]
  • [ 392331-66-7 ]
YieldReaction ConditionsOperation in experiment
95% With ammonium hydroxide; In methanol; at 80℃; for 16h;Sealed tube; A 100-mL sealed tube fitted with a magnetic stir bar was charged with tert-Butyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate (300 mg, 1.28 mmol) and a solution of ammonium hydroxide in methanol (20 mL, 7M). The solution was stirred for 16 h at 80 C. in an oil bath and cooled to room temperature. The mixture was concentrated under vacuum to afford tert-butyl 4-(aminomethyl)-4-hydroxypiperidine-1-carboxylate (350 mg, >95%) used without further purification. LCMS (ESI) m/z 231 [M+H].
86% With ammonia; In methanol; at 20℃; for 12h; To a stirred solution of tert-butyl 1-oxa-6-aza-spiro[2.5]octane-6-carboxylate (0.64 grams, 3.0 mmol, obtained in the above step) in methanol (4 mL) at room temperature, a solution of ammonia (NH3) in methanol (7M, 8 mL) was added and the reaction was stirred for12 hours. The volatiles were removed under reduced pressure to obtain the crude mass which was triturated with hexanes and ether which yielded the above titled compound (0.6 gram). Yield: 86 %.?H - NMR CDCI3 (6 ppm): 1.45 (9H, s), 1.35 - 1.60 (4H, m), 2.63 (2H, s), 3.10 - 3.25 (2H, m), 3.80 - 3.95 (2H, m).Mass (m/z): 231.5 (M+H)4.
86% With ammonia; In methanol; at 20℃; for 12h; To a stirred solution of N-tert butyloxycarbonyl1-oxa-6-aza-spiro[2.5]octane 21 (0.64 g, 3.0 mmols) in methanol(4.0 mL) at r.t., a solution of ammonia (NH3)in methanol (7M, 8.0 mL) was added and the reaction was stirred for 12 hours.The volatiles were removed under reduced pressure to obtain the crude masswhich was triturated with hexanes and ether which yielded the above titledcompound 22c (0.6 g) in 86% yield.1H - NMR CDCl3 (CDCl3): d 3.95 - 3.80 (m, 2H), 3.25 -3.10 (m, 2H), 2.63 (s, 2H), 1.35 - 1.60 (m, 4H), 1.45 (s, 9H). Mass (m/z): 231.5 (M+H)+. Anal. (C11H22N2O3) C, H, N
76% With ammonia; In methanol; at 25 - 40℃; for 40h; tert-Butyl l-Oxa-6-aza-spiro[2.5]octane-6-carboxylate (0.5 grams, 2.34 mmole) was added to methanolic ammonia solution (20 mL, 14.83 % w/v) at room temperature. Then reaction mass was stirred for 40 hours at room temperature in a closed vessel. The progress of the reaction was monitored by TLC. After completion of the reaction (TLC), the reaction mass was concentrated on rotavacuum to obtain the title compound. Yield: 0.41 gram (76%). 'H-NMR(8 ppm): 1.35 - 1.69 (16H, m), 2.61 (2H, s), 3.10 - 3.20 (2H, m), 3.81 -3.90(2H, m); Mass (m/z): 231.3 (M+H)+.
76% With ammonia; In methanol; at 20℃; for 40h; tert-Butyl l-oxa-6-azaspiro[2.5]octane-6-carboxylate (0.5 grams, 2.34 mmole, obtained in the step (i) of preparation 5) was added to methanolic ammonia solution (20 mL, 14.83 % w/v) at RT. Then reaction mass was stirred for 40 hours at RT in a closed vessel. The reaction mass was concentrated under vacuum to obtain the title compound. Weight: 0.41 gram (Yield: 76 %). (0385) - NMR (delta ppm): 1.35 - 1.69 (16H, m), 2.61 - 2.69 (2H, m), 3.10 - 3.20 (2H, m), 3.81 - 3.90 (2H, m); (0386) Mass (m/z): 231.3 (M+H)+ .
69% With ammonia; In methanol; at 20℃; Intermediate 2M: tert-butyl 4-(amiriomethyl)-4-hydroxypiperidine-1 -carboxylate A mixture of intermediate 1A (10.0 g, 46.9 mmol) and ammonia solution (201 mL, 7 M solution in methanol, 1.4 mol) was stirred at r.t. overnight. The solvent was removedunder vacuum and the residue was purified by flash chromatography, silica gel, gradient dichioromethane to methanol:dichloromethane (1:4) to give the title compound (7.4 g, 69% yield) as a white solid. HPLC retention time: 2.15 mm; MS:131 (M+H-100).
69% With ammonia; In methanol; at 20℃; A solution of intermediate 1A (10.0 g, 46.9 mmol) in ammonia (201 ml_, 7 M solution in methanol, 1.4 mol) was stirred at r.t. overnight. The solvent was removed under vacuum and the residue was purified by flash chromatography, silica gel, gradient dichloromethane to methanokdichloromethane (1 :4) to give the title compound (7.4 g, 69% yield) as a white solid. HPLC retention time: 2.15 min; MS: 131 (M+H-100).
69% With ammonia; In methanol; at 20℃; Intermediate 2A: fert-butyl 4-(aminomethyl)-4-hydroxypiperidine-1-carboxylate A mixture of intermediate 1A (10.0 g, 46.9 mmol) and ammonia solution (201 mL, 7 M solution in methanol, 1.4 mol) was stirred at r.t. overnight. The solvent was removed under vacuum and the residue was purified by flash chromatography, silica gel, gradient dichloromethane to methanokdichloromethane (1 :4) to give the title compound (7.4 g, 69% yield) as a white solid. HPLC retention time: 2.15 min; MS: 131 (M+H-100).
60.5% With ammonia; In ethanol; water;Inert atmosphere; A stirred solution of 1-oxa-6-aza-spiro[2.5]octane-6-carboxylic acid tert-butyl ester (9.0 g, 42.2 mmol) in ethanol (60 ml) was added with ammonia (100 ml). The resulting mixture was stirred under a nitrogen atmosphere overnight. The mixture was concentrated under reduced pressure. The residue was added with water (50 ml) and extracted with ethyl acetate (150 ml*3). The combined organic extracts were dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography with dichloromethane:methanol (20:1) as eluents to give 4-aminomethyl-4-hydroxy-piperidine-1-carboxylic acid tert-butyl ester (5.87 g, 60.5%) as a white solid. MS m/z (ESI): 231 [M+1]
60.5% With ammonia; In ethanol; A stirred solution of l-oxa-6-aza-spiro [2.5] octane-6-carboxylic acid tert-butyl ester (9.0 g, 42.2 mmol) in ethanol(60 ml) was added with ammonia (100 ml). The resulting mixture was stirred under a nitrogen atmosphere overnight. The mixture was concentrated under reduced pressure. The residue was added with water (50 ml) and extracted with ethyl acetate (150 ml><3). The combined organic extracts were dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography with dichloromethane: methanol (20:1) as eluents to give 4-aminomethyl-4-hydroxy-piperidine-l-carboxylic acid tert-butyl ester (5.87 g, 60.5%) as a white solid. MS m/z (ESI): 231[M+1] ,
With ammonia; In methanol; water; at 0 - 20℃; for 7h; 4-Aminomethyl-4-hydroxy-piperidine-1-carboxylic acid tert-butyl ester is prepared from 1-oxa-6-aza-spiro[2.5]octane-6-carboxylic acid tert-butyl ester (Bourrain et al Bioorg. Med. Chem. Lett. 9(23):3369-3374 (1999)). Concentrated aqueous NH4OH (6 mL) is added to a solution of 1-oxa-6-aza-spiro[2.5]octane-6-carboxylic acid tert-butyl ester (0.50 g, 2.3 mmol) in MeOH (4 mL) at 0 C. The reaction mixture is removed from the cooling and allowed to warm to room temperature. After 7 hours, the reaction mixture is concentrated under reduced pressure to afford desired product as a white solid.
With ammonium hydroxide; In methanol; at 0 - 20℃; for 16h; aqueous ammonia (6mL)was added to a solution of tert-butyl 1-oxa-6-azaspiro[2.5]octan-6-carboxylate (500mg, 2mmol) in methanol (4mL) at0C. The reaction solution warmed to room temperature and was stirred for 16 hours, then concentrated under reduced pressure to give a colorless oil (530mg, 2.3mmol) with a yield of 100%, which was used directly in the next step withoutpurification.

  • 2
  • [ 19181-54-5 ]
  • [ 147804-30-6 ]
  • tert-butyl 4-hydroxy-4-((8-methyl-4-oxoquinazolin-3(4H)-yl)methyl)piperidine-1-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
With caesium carbonate; In N,N-dimethyl-formamide; at 80℃; for 16h; To a solution of <strong>[19181-54-5]8-methylquinazolin-4(3H)-one</strong> (20 mg, 0.125 mmol) and tert-butyl 1-oxa-6-azaspiro[2.5]octane-6-carboxylate (33 mg, 0.156 mmol) in DMF (0.625 mL) was added cesium carbonate (122 mg, 0.375 mmol). The reaction mixture was stirred at 80 C. for 16 h, then cooled to room temperature, diluted with ethyl acetate (0.5 mL) and washed with water (0.5 mL). The organic layer was concentrated under reduced pressure to afford tert-butyl 4-hydroxy-4-((8-methyl-4-oxoquinazolin-3(4H)-yl)methyl)piperidine-1-carboxylate, which was used without further purification. LCMS: (ESI) m/z 396.29 [M+Na].
  • 3
  • [ 403-01-0 ]
  • [ 147804-30-6 ]
  • C19H26FNO6 [ No CAS ]
YieldReaction ConditionsOperation in experiment
63% With lithium perchlorate; In acetonitrile; at 80℃; (2)Compound j (8 g, 1.0 eq), compound k (1.5 eq), lithium perchlorate (1.7 eq) and acetonitrile (50 ml) were added to a three-necked flask, and the mixture was heated to 80 ° C to stir the reaction for 12-18 h.Cool down to room temperature,Diluted with 200 ml of ethyl acetate.Wash with saturated brine and dry over anhydrous sodium sulfate.Concentrate the organic phase to dryness, over the fast column,Obtaining 9.06 g of compound l,Yield: 63percent.
  • 4
  • [ 20872-93-9 ]
  • [ 147804-30-6 ]
  • C19H24N4O6 [ No CAS ]
  • 5
  • [ 403-01-0 ]
  • [ 147804-30-6 ]
  • C19H25NO6 [ No CAS ]
YieldReaction ConditionsOperation in experiment
6.37 g (2) Compound j (8 g, 1.0 eq), compound k (1.5 eq), lithium perchlorate (1.7 eq) and acetonitrile (50 ml) were added to a three-necked flask, heated to 80 ° C and stirred for 12-18 h. After completion, the mixture was cooled to room temperature, diluted with 200 ml of ethyl acetate, washed with saturated brine, dried over anhydrous sodium sulfateObtaining 9.06 g of compound l,Yield: 63percent. (3) Compound l (8g, 1.0 eq), cesium carbonate (1.5 eq) and acetonitrile (50 ml) were added to a three-necked flask, heated to 60 ° C and stirred for 6-8 h. After the reaction was completed, the temperature was lowered to room temperature, and 200 ml was added. Diluted with ethyl acetate, washed with saturated brine, dried over anhydrous sodium sulfate6.37 g of compound m was obtained in a yield: 84percent.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 147804-30-6 ]

Amides

Chemical Structure| 140695-85-8

[ 140695-85-8 ]

(R)-tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 116574-71-1

[ 116574-71-1 ]

tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 240401-27-8

[ 240401-27-8 ]

tert-Butyl 2-oxa-7-azaspiro[3.5]nonane-7-carboxylate

Similarity: 0.92

Chemical Structure| 140695-84-7

[ 140695-84-7 ]

tert-Butyl (S)-3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 1209319-87-8

[ 1209319-87-8 ]

tert-Butyl 2-oxo-1-oxa-3,9-diazaspiro[5.5]undecane-9-carboxylate

Similarity: 0.92

Related Parent Nucleus of
[ 147804-30-6 ]

Aliphatic Heterocycles

Chemical Structure| 140695-85-8

[ 140695-85-8 ]

(R)-tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 116574-71-1

[ 116574-71-1 ]

tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 240401-27-8

[ 240401-27-8 ]

tert-Butyl 2-oxa-7-azaspiro[3.5]nonane-7-carboxylate

Similarity: 0.92

Chemical Structure| 140695-84-7

[ 140695-84-7 ]

tert-Butyl (S)-3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 1209319-87-8

[ 1209319-87-8 ]

tert-Butyl 2-oxo-1-oxa-3,9-diazaspiro[5.5]undecane-9-carboxylate

Similarity: 0.92

Epoxides

Chemical Structure| 276872-90-3

[ 276872-90-3 ]

tert-Butyl 1-oxa-5-azaspiro[2,5]octane-5-carboxylate

Similarity: 0.91

Chemical Structure| 161157-50-2

[ 161157-50-2 ]

tert-Butyl 7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate

Similarity: 0.88

Chemical Structure| 301226-25-5

[ 301226-25-5 ]

tert-Butyl 1-oxa-5-azaspiro[2.4]heptane-5-carboxylate

Similarity: 0.86

Chemical Structure| 114214-49-2

[ 114214-49-2 ]

tert-Butyl 6-oxa-3-azabicyclo[3.1.0]hexane-3-carboxylate

Similarity: 0.78

Chemical Structure| 247068-82-2

[ 247068-82-2 ]

tert-Butyl ((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate

Similarity: 0.66

Piperidines

Chemical Structure| 140695-85-8

[ 140695-85-8 ]

(R)-tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 116574-71-1

[ 116574-71-1 ]

tert-Butyl 3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 240401-27-8

[ 240401-27-8 ]

tert-Butyl 2-oxa-7-azaspiro[3.5]nonane-7-carboxylate

Similarity: 0.92

Chemical Structure| 140695-84-7

[ 140695-84-7 ]

tert-Butyl (S)-3-(hydroxymethyl)piperidine-1-carboxylate

Similarity: 0.92

Chemical Structure| 1209319-87-8

[ 1209319-87-8 ]

tert-Butyl 2-oxo-1-oxa-3,9-diazaspiro[5.5]undecane-9-carboxylate

Similarity: 0.92

Spiroes

Chemical Structure| 240401-27-8

[ 240401-27-8 ]

tert-Butyl 2-oxa-7-azaspiro[3.5]nonane-7-carboxylate

Similarity: 0.92

Chemical Structure| 1209319-87-8

[ 1209319-87-8 ]

tert-Butyl 2-oxo-1-oxa-3,9-diazaspiro[5.5]undecane-9-carboxylate

Similarity: 0.92

Chemical Structure| 276872-90-3

[ 276872-90-3 ]

tert-Butyl 1-oxa-5-azaspiro[2,5]octane-5-carboxylate

Similarity: 0.91

Chemical Structure| 374794-96-4

[ 374794-96-4 ]

tert-Butyl 2-oxa-8-azaspiro[4.5]decane-8-carboxylate

Similarity: 0.91

Chemical Structure| 173405-78-2

[ 173405-78-2 ]

tert-Butyl 3,9-diazaspiro[5.5]undecane-3-carboxylate

Similarity: 0.88

; ;